Dow up 0.51% Nasdaq up 0.24%
{"s" : "^dji,^ixic","k" : "p20","o" : "","j" : ""}
 Dow up 0.51% Nasdaq up 0.24%
{"s" : "^dji,^ixic","k" : "p20","o" : "","j" : ""}

Quote Results

Add Quotes

Insulet Corporation

(NasdaqGS: PODD)

Last Trade:45.26 Day's Range45.20 - 46.70
Trade Time:Nov 21 52wk Range:30.04 - 51.31
Change: down-0.20 (-0.44%) Volume:477,012
Prev Close:45.46 Avg Vol (3m):487,246
Open:46.26 Market Cap:2.54B
Bid:20 x 100 P/E (ttm):N/A
Ask:50 x 100 EPS (ttm):-0.88
1Y Target Est:45.23 Div & Yield: N/A (N/A)

Similar CompaniesACL COV BAX BDX EI.PA

Quotes delayed, except where indicated otherwise. PODD currency is USD.

Chart showing the development of {0:name}
{"s" : "podd","k" : "l84,g53,h53,t53,c63,p43,v53,j10,b00,b60,a00,a50","o" : "podd","j" : "l84,g53,h53,t53,c63,p43,v53,j10,b00,b60,a00,a50"}

Recent News

day and time symbols news headline and source
Friday November 14, 2014
INSULET CORP Financials EDGAR Online Financials01:04pm EST
Friday November 7, 2014
10-Q for Insulet Corp. Company Spotlight07:08pm EST
Wednesday November 5, 2014
Insulet tops 3Q profit forecasts AP05:27pm EST
INSULET CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Principal Officer EDGAR Online04:47pm EST
Insulet Corporation Appoints New Chief Financial Officer and Executive Vice President, Human Resources Marketwired04:07pm EST
Insulet Reports Third Quarter 2014 Results Marketwired04:05pm EST
Q3 2014 Insulet Corp Earnings Release - After Market Close CCBN07:07am EST
Monday November 3, 2014
Insulet Corporation to Present at Upcoming Investor Conferences Marketwired04:15pm EST
Tuesday October 21, 2014
Insulet Corporation to Report Third Quarter 2014 Financial Results on November 5, 2014 Marketwired04:15pm EDT
Thursday October 9, 2014
Capricor Therapeutics Announces Plans to Pursue a Cenderitide Clinical Program and Enters Into Research Support Agreement With Insulet Corporation GlobeNewswire08:22am EDT
Tuesday September 16, 2014
INSULET CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Principal Officer EDGAR Online05:00pm EDT
Insulet Corporation Appoints Patrick J. Sullivan as President and Chief Executive Officer Marketwired04:30pm EDT
Tuesday September 2, 2014
Insulet Corporation to Present at the Morgan Stanley Global Healthcare Conference Marketwired04:05pm EDT
Friday August 15, 2014
INSULET CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online04:33pm EDT
Insulet Appoints Timothy J. Scannell to Board of Directors Marketwired04:30pm EDT
Thursday August 7, 2014
INSULET CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online04:38pm EDT
Insulet Reports Second Quarter 2014 Results Marketwired04:05pm EDT
Tuesday August 5, 2014
Insulet and Dexcom Agree to Develop a CGM-Integrated Personal Diabetes Manager Marketwired04:05pm EDT
Friday August 1, 2014
Insulet Corporation to Present at the Canaccord Genuity 34th Annual Growth Conference Marketwired04:15pm EDT
Wall Street Transcript Interview with Christopher Clark, the CFO of Neovasc Inc. (NVCN) Wall Street Transcript12:07pm EDT
Tuesday July 29, 2014
Insulet Corporation to Report Second Quarter 2014 Financial Results on August 7, 2014 Marketwired04:15pm EDT
Friday June 27, 2014
INSULET CORP Files SEC form 8-K, Other Events EDGAR Online04:49pm EDT